BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 32787970)

  • 1. G6PD deficiency in malaria endemic areas of Nepal.
    Marasini B; Lal BK; Thapa S; Awasthi KR; Bajracharya B; Khanal P; Neupane S; Jha SN; Acharya S; Iama S; Koirala M; Koirala D; Bhandari S; Mahato RK; Chaudhary A; Ghimire P; Magar RG; Bhattarai RK; Gornsawun G; Penpitchaporn P; Bancone G; Acharya BP
    Malar J; 2020 Aug; 19(1):287. PubMed ID: 32787970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose-6-phosphate dehydrogenase deficiency in people living in malaria endemic districts of Nepal.
    Ghimire P; Singh N; Ortega L; Rijal KR; Adhikari B; Thakur GD; Marasini B
    Malar J; 2017 May; 16(1):214. PubMed ID: 28535765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of G6PD deficiency and submicroscopic malaria parasites carriage in malaria hotspot area in Northwest, Tanzania.
    Manjurano A; Lyimo E; Kishamawe C; Omolo J; Mosha J; Donald M; Kazyoba P; Kapiga S; Changalucha J
    Malar J; 2023 Dec; 22(1):372. PubMed ID: 38062464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of glucose-6-phosphate dehydrogenase (G6PD) deficiency prevalence in a Plasmodium vivax-endemic area in the Republic of Korea (ROK).
    Lee W; Lee SE; Lee MJ; Noh KT
    Malar J; 2020 Sep; 19(1):317. PubMed ID: 32873296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and distribution of G6PD deficiency: implication for the use of primaquine in malaria treatment in Ethiopia.
    Lo E; Zhong D; Raya B; Pestana K; Koepfli C; Lee MC; Yewhalaw D; Yan G
    Malar J; 2019 Oct; 18(1):340. PubMed ID: 31590661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G6PD deficiency alleles in a malaria-endemic region in the Western Brazilian Amazon.
    Dombrowski JG; Souza RM; Curry J; Hinton L; Silva NRM; Grignard L; Gonçalves LA; Gomes AR; Epiphanio S; Drakeley C; Huggett J; Clark TG; Campino S; Marinho CRF
    Malar J; 2017 Jun; 16(1):253. PubMed ID: 28619120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and genetic variants of G6PD deficiency among two Malagasy populations living in Plasmodium vivax-endemic areas.
    Howes RE; Chan ER; Rakotomanga TA; Schulte S; Gibson J; Zikursh M; Franchard T; Ramiranirina B; Ratsimbasoa A; Zimmerman PA
    Malar J; 2017 Apr; 16(1):139. PubMed ID: 28376871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of G6PD Viangchan variant in malaria endemic areas in Lao PDR: an implication for malaria elimination by 2030.
    Ong KIC; Iwagami M; Araki H; Khattignavong P; Soundala P; Keomalaphet S; Prasayasith P; Lorpachan L; Xangsayalath P; Pongvongsa T; Hongvanthong B; Brey PT; Kano S; Jimba M
    Malar J; 2019 Mar; 18(1):75. PubMed ID: 30866940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose-6-phosphate dehydrogenase deficiency prevalence and genetic variants in malaria endemic areas of Colombia.
    Valencia SH; Ocampo ID; Arce-Plata MI; Recht J; Arévalo-Herrera M
    Malar J; 2016 May; 15(1):291. PubMed ID: 27225440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and molecular characterization of G6PD deficiency in two Plasmodium vivax endemic areas in Venezuela: predominance of the African A-(202A/376G) variant.
    Vizzi E; Bastidas G; Hidalgo M; Colman L; Pérez HA
    Malar J; 2016 Jan; 15():19. PubMed ID: 26753754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose-6-phosphate dehydrogenase mutations in malaria endemic area of Thailand by multiplexed high-resolution melting curve analysis.
    Boonyuen U; Songdej D; Tanyaratsrisakul S; Phuanukoonnon S; Chamchoy K; Praoparotai A; Pakparnich P; Sudsumrit S; Edwards T; Williams CT; Byrne RL; Adams ER; Imwong M
    Malar J; 2021 Apr; 20(1):194. PubMed ID: 33879156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemolysis in G6PD Heterozygous Females Treated with Primaquine for Plasmodium vivax Malaria: A Nested Cohort in a Trial of Radical Curative Regimens.
    Chu CS; Bancone G; Moore KA; Win HH; Thitipanawan N; Po C; Chowwiwat N; Raksapraidee R; Wilairisak P; Phyo AP; Keereecharoen L; Proux S; Charunwatthana P; Nosten F; White NJ
    PLoS Med; 2017 Feb; 14(2):e1002224. PubMed ID: 28170391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose-6-phosphate dehydrogenase (G6PD) deficiency in Ethiopia: absence of common African and Mediterranean allelic variants in a nationwide study.
    Assefa A; Ali A; Deressa W; Tsegaye W; Abebe G; Sime H; Kebede A; Jima D; Kassa M; Abreha T; Teka H; Solomon H; Malone J; Shi YP; Zhou Z; Reithinger R; Hwang J
    Malar J; 2018 Oct; 17(1):388. PubMed ID: 30367627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid diagnostic test and associated genetic variants in Plasmodium vivax malaria endemic setting in Mauritania.
    Djigo OKM; Bollahi MA; Hasni Ebou M; Ould Ahmedou Salem MS; Tahar R; Bogreau H; Basco L; Ould Mohamed Salem Boukhary A
    PLoS One; 2019; 14(9):e0220977. PubMed ID: 31525211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of G6PD deficiency and distribution of its genetic variants among malaria-suspected patients visiting Metehara health centre, Eastern Ethiopia.
    Shenkutie TT; Nega D; Hailu A; Kepple D; Witherspoon L; Lo E; Negash MT; Adamu A; Gebremichael SG; Gidey B; Tasew G; Feleke SM; Kebede T
    Malar J; 2022 Sep; 21(1):260. PubMed ID: 36076204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of G6PD deficiency and diagnostic accuracy of a G6PD point-of-care test among a population at risk of malaria in Myanmar.
    Aung TH; Suansomjit C; Tun ZM; Hlaing TM; Kaewkungwal J; Cui L; Sattabongkot J; Roobsoong W
    Malar J; 2023 May; 22(1):143. PubMed ID: 37127600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of G6PD deficiency and associated haematological parameters in children from Botswana.
    Motshoge T; Ababio G; Aleksenko L; Souda S; Muthoga CW; Mutukwa N; Tawe L; Ramatlho P; Gabaitiri L; Chihanga S; Mosweunyane T; Hamda S; Moakofhi K; Ntebela D; Peloewetse E; Mazhani L; Pernica JM; Read J; Quaye IK; Paganotti GM
    Infect Genet Evol; 2018 Sep; 63():73-78. PubMed ID: 29778768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of glucose-6-phosphate dehydrogenase (G6PD) activity during Plasmodium vivax infection: implications for early radical malaria treatment.
    Dahuron L; Goungounga J; Drame M; Douine M; Nacher M; Blaise T; Mosnier E; Musset L; Fouillet M; Djossou F; Epelboin L
    Malar J; 2024 May; 23(1):140. PubMed ID: 38725027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and molecular basis of glucose-6-phosphate dehydrogenase deficiency in Afghan populations: implications for treatment policy in the region.
    Leslie T; Moiz B; Mohammad N; Amanzai O; Ur Rasheed H; Jan S; Siddiqi AM; Nasir A; Beg MA; Vink M
    Malar J; 2013 Jul; 12():230. PubMed ID: 23834949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and risk factors for asymptomatic malaria and genotyping of glucose 6-phosphate (G6PD) deficiencies in a vivax-predominant setting, Lao PDR: implications for sub-national elimination goals.
    Lover AA; Dantzer E; Hongvanthong B; Chindavongsa K; Welty S; Reza T; Khim N; Menard D; Bennett A
    Malar J; 2018 Jun; 17(1):218. PubMed ID: 29859089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.